As one of the NIHR MedTech and In Vitro Diagnostics Co-operatives (MICs) we work in partnership with a number of key parts of the healthcare and academic community to deliver our remit including the Academic Health Science Networks.
We are grateful for the support of the National Office for Clinical Research Infrastructure (NOCRI) who co-ordinate activities across NIHR funded programmes and provide a single access point to the MICs and other clinical research infrastructure.
As a MIC we work closely with industry and their trade bodies, including the British In Vitro Diagnostic Association (BIVDA), to ensure that we tailor our approach to meet industry need.
We are part of a wider Diagnostics North East initiative, helping diagnostic researchers with every stage of their research including development, evaluation and
adoption of their technologies into healthcare systems. This includes working closely with the Academic Health Science Network for the North East and North Cumbria (AHSN-NENC), MEDConNecT North, Newcastle Molecular Pathology Node, CEPA Biobank Newcastle and The National Institute for Health Care Excellence External Assessment Centre (NICE EAC).
We work closely with our regional NIHR infrastructure partners including the NIHR Innovation Observatory, NIHR Newcastle Biomedical Research Centre (Newcastle BRC), NIHR Clinical Research Network North East and North Cumbria (CRN NENC), NIHR Research Design Service North East and North Cumbria (RDS NENC), NIHR School for Public Health, NIHR Newcastle Clinical Trials Unit (Newcastle CTU) and NIHR Newcastle Clinical Research Facility (Newcastle CRF)
We collaborate regularly with Regional Medical Physics and the Newcastle University Institute of Health and Society, School of Mathematics, Statistics and Physics and Stroke Research Group.
We recognise the importance of engaging and involving patients and the public with our research. We are forming relationships with disease related charities, patient liaison groups and public research support groups such as VOICE.
